Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 5/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.70 |
| ▸ | HPGD | P15428 | 4/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.70 |
| ▸ | NPC1 | O15118 | 3/20 | 0.70 |
| ▸ | RAB9A | P51151 | 3/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.70 |
| ▸ | ATM | Q13315 | 1/20 | 0.70 |
| ▸ | ESR1 | P03372 | 1/20 | 0.65 |
| ▸ | SHBG | P04278 | 1/20 | 0.65 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.65 |
| ▸ | TTR | P02766 | 1/20 | 0.63 |
| ▸ | GAA | P10253 | 3/20 | 0.61 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 5/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1245832 | 1.00 | MEN1 (0.70) | MEN1KMT2ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL1039742 | 0.91 | SMN1; SMN2 (0.70) | MEN1KMT2ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL29535799 | 0.90 | NPC1 (0.68) | MEN1KMT2ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL1245285 | 0.90 | NPC1 (0.68) | MEN1KMT2ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL31511913 | 0.89 | SMN1; SMN2 (0.70) | MEN1KMT2ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL8168221 | 0.89 | SMN1; SMN2 (0.70) | MEN1KMT2ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL1840837 | 0.86 | MEN1 (0.67) | MEN1KMT2ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL14156958 | 0.86 | ESR1 (0.61) | MEN1KMT2ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL31511909 | 0.86 | MEN1 (0.67) | MEN1KMT2ASMN1; SMN2HPGDALDH1A1 | |
| Ononetin SCHEMBL2948430 | 0.82 | NPC1 (1.00) | MEN1KMT2ASMN1; SMN2HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108366597-B | Substance mixture | 西姆莱斯有限公司 | 2022-09-02 | — | — | CN | claimed |
| US-12557831-B2 | Mogrosides and uses of the same | THE COCA-COLA COMPANY (US) | 2026-02-24 | — | — | US | disclosed |
| EP-3522737-B1 | DITERPENE GLYCOSIDES CONTAINING AN ENT-ATISENE CORE, COMPOSITIONS AND METHODS | COCA COLA CO (US) | 2025-12-03 | — | — | EP | disclosed |
| US-20250084049-A1 | POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF | FIRMENICH INCORPORATED (US) | 2025-03-13 | — | — | US | disclosed |
| EP-3528640-B1 | DITERPENE GLYCOSIDES ISOLATED FROM STEVIA, COMPOSITIONS AND METHODS | COCA COLA CO (US) | 2025-01-15 | — | — | EP | disclosed |
| EP-4469439-A1 | NEW COOLANTS, AND PREPARATIONS CONTAINING SAME | Symrise AG (DE) | 2024-12-04 | — | — | EP | disclosed |
| CN-118984825-A | Novel cooling agent and preparation containing same | 西姆莱斯股份公司 | 2024-11-19 | — | — | CN | disclosed |
| EP-4452941-A1 | ACTIVE INGREDIENTS WITH SIALAGOGUE AND TINGLING/FIZZY EFFECT, AND PREPARATIONS CONTAINING SAME | Symrise AG (DE) | 2024-10-30 | — | — | EP | disclosed |
| EP-4247791-A2 | NEW COOLANTS, AND PREPARATIONS CONTAINING SAME | Symrise AG (DE) | 2023-09-27 | — | — | EP | disclosed |
| CN-116685575-A | Novel cooling substances and formulations containing these cooling substances | 西姆莱斯股份公司 | 2023-09-01 | — | — | CN | disclosed |
| WO-2023144326-A1 | NEW COOLANTS, AND PREPARATIONS CONTAINING SAME | SYMRISE AG (DE) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023143741-A1 | NEW COOLANTS, AND PREPARATIONS CONTAINING SAME | SYMRISE AG (DE) | 2023-08-03 | — | — | WO | disclosed |
| CN-109890221-B | Diterpene glycosides containing an ent-acteosene core, compositions, and methods | 可口可乐公司 | 2023-04-14 | — | — | CN | disclosed |
| US-20230115269-A1 | Diterpene Glycosides Isolated from Stevia, Compositions and Methods | THE COCA-COLA COMPANY | 2023-04-13 | — | — | US | disclosed |
| EP-4103575-A1 | ALLULOSE IN CRYSTALLINE FORM | Savanna Ingredients GmbH (DE) | 2022-12-21 | — | — | EP | disclosed |
| CN-108366597-B | Substance mixture | 西姆莱斯有限公司 | 2022-09-02 | — | — | CN | disclosed |
| WO-2022106452-A2 | NEW COOLANTS, AND PREPARATIONS CONTAINING SAME | SYMRISE AG (DE) | 2022-05-27 | — | — | WO | disclosed |
| WO-2022105986-A1 | NOVEL COOLING AGENTS AND PREPARATIONS CONTAINING SAME | SYMRISE AG (DE) | 2022-05-27 | — | — | WO | disclosed |
| CN-109310130-B | Cooling substance mixture | 西姆莱斯股份公司 | 2022-05-17 | — | — | CN | disclosed |
| US-20220142216-A1 | Novel Mogrosides and Uses of the Same | THE COCA-COLA COMPANY | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250084049-A1 | POLYCATIONIC SALTS OF PHENOLIC COMPOUNDS AND USES THEREOF | PGC, SLC5A6, PUF60 | MEN1 2672/4885KMT2A 741/4885SMN1; SMN2 2952/4885 |
| US-12557831-B2 | Mogrosides and uses of the same | TAS2R40, TAS2R20, TAS2R10 | MEN1 2170/4885KMT2A 1530/4885SMN1; SMN2 1588/4885 |
| US-20230115269-A1 | Diterpene Glycosides Isolated from Stevia, Compositions and Methods | GYPA, DDOST, TAS2R7 | MEN1 1532/4885KMT2A 2952/4885SMN1; SMN2 3193/4885 |
| US-20220142216-A1 | Novel Mogrosides and Uses of the Same | MAG, UGGT1, OGT | MEN1 1686/4885KMT2A 3389/4885SMN1; SMN2 983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.